Flavanol-rich cocoa: A cardioprotective nutriceutical

Cardiology in Review

Volumn 16, Issue 3, 2008, Pages 109-115

  Mehrinfar, Ramona ^a   Frishman, William H ^b,c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b WESTCHESTER MEDICAL CENTER   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Chocolate; Cocoa; Flavanol; Flavonoid

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ANTHOCYANIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPICATECHIN; FIBRINOGEN RECEPTOR; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL; LIPOXYGENASE; NUTRACEUTICAL; PLACEBO; PROANTHOCYANIDIN DERIVATIVE; PROCYANIDIN DERIVATIVE; REACTIVE NITROGEN SPECIES; THROMBOXANE;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; CACAO; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CHEMICAL STRUCTURE; ENDOTHELIUM; FOOD PROCESSING; HEALTH FOOD; HEART PROTECTION; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; LOW DRUG DOSE; METABOLISM; MONOTHERAPY; REVIEW; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; VOLUNTEER;

ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; BLOOD PRESSURE; CACAO; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FLAVONOIDS; FOOD HANDLING; HUMANS; HYPERTENSION; INFLAMMATION; PHYTOTHERAPY; PLANT EXTRACTS; PLATELET AGGREGATION;

EID: 42249097080     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e31815d95e2     Document Type: Review

References (57)

1. Kris-Etherton PM, Keen CL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol. 2002;13:41-49.
2. Hollenberg NK, Martinez G, McCullough M, et al. Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension. 1997;29:171-176.
3. Bayard V, Chamorro F, Motta J, et al. Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama. Int J Med Sci. 2007;4:53-58.
4. Lee KW, Kim YJ, Lee HJ, et al. Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. J Agric Food Chem. 2003;51:7292-7295.
5. Vinson JA, Proch J, Zubik L. Phenol antioxidant quantity and quality in foods: cocoa, dark chocolate, and milk chocolate. J Agric Food Chem. 1999;47:4821-4824.
6. Gertner J. Eat chocolate, live longer? New York Times, October 10, 2004.
7. Hannum SM, Erdman JW. Emerging health benefits from cocoa and chocolate. J Med Food. 2000;3:73-75.
8. Porter LJ, Ma Z, Chan B. Cacao procyanidins: major flavonoids and identification of some minor metabolites. Phytochem. 1991;30:1657-1663.
9. Hammerstone JF, Lazarus SA, Mitchell AE, et al. Identification of procyanidins in cocoa (Theobroma cacao) and chocolate using high-performance liquid chromatography/mass spectrometry. J Agric Food Chem. 1999;47:490-496.
10. Spencer JP, Schroeter H, Kuhnle G, et al. Epicatechin and its in vivo metabolite, 3′-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. Biochem J. 2001;354(Pt 3):493-500.
11. Ding EL, Hutfless SM, Ding X, et al. Chocolate and prevention of cardiovascular disease: a systematic review. Nutr Metab (Lond). 2006;3:2.
12. Holt RR, Lazarus SA, Sullards M, et al. Procyanidin dimer B2 (epicatechin-(4β-8)-epicatechin) in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr. 2002;76:798-804.
13. Spencer JP, Schroeter H, Shenoy B, et al. Epicatechin is the primary bioavailable form of the procyanidin dimers B2 and B5 after transfer across the small intestine. Biochem Biophys Res Commun. 2001;285:588-593.
14. Rios L, Bennett R, Lazarus C, et al. Cocoa procyanidins are stable during transit in humans. Am J Clin Nutr. 2002;76:1106-1110.
15. Donovan JL, Crespy V, Manach C, et al. Catechin is metabolized by both the small intestine and liver of rats. J Nutr. 2001;131:1753-1757.
16. Spencer JP. Metabolism of tea flavonoids in the gastrointestinal tract. J Nutr. 2003;133:3255S-3261S.
17. Baba S, Osakabe N, Yasuda A, et al. Bioavailability of (-)-epicatechin upon intake of chocolate and cocoa in human volunteers. Free Radic Res. 2000;33:635-641.
18. Mira L, Fernandez MT, Santos M, et al. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res. 2002;36:1199-1208.
19. Pearson DA, Schmitz HH, Lazarus SA, et al. Inhibition of in vitro low-density lipoprotein oxidation by oligomeric procyanidins present in chocolate and cocoas. In: Packer L, ed. Methods in Enzymology. New York, NY: Academic Press; 2001:350-360.
20. Sanbongi C, Suzuki N, Sakane T. Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in vitro. Cell Immunol. 1997;177:129-136.
21. Ottavani JI, Carrasquedo F, Keen CL, et al. Influence of flavan-3-ols and procyanidins on UVC-mediated formation of 8-oxo-7,8-dihydro-2′- deoxyguanosine in isolated DNA. Arch Biochem Biophys. 2002;406:203-208.
22. Kraemer T, Prakosay I, Date RA, et al. Oxidative modification of low-density lipoprotein: lipid peroxidation by myeloperoxidase in the presence of nitrite. Biol Chem. 2004;385:809-818.
23. Kostyuk VA, Kraemer T, Sies H, et al. Myeloperoxidase/nitrite-mediated lipid peroxidation of low-density lipoprotein as modulated by flavonoids. FEBS Lett. 2003;537:146-150.
24. Wan Y, Vinson JA, Etherton TD, et al. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr. 2001;74:596-602.
25. Osakabe N, Baba S, Yasuda A, et al. Daily cocoa intake reduces the susceptibility of low-density lipoprotein to oxidation as demonstrated in healthy human volunteers. Free Radic Res. 2001;34:93-99.
26. Mursu J, Voutilainen S, Nurmi T, et al. Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans. Free Radic Biol Med. 2004;37:1351-1359.
27. Steinberg FM, Holt RR, Schmitz HH, et al. Cocoa procyanidin chain length does not determine ability to protect LDL from oxidation when monomer units are controlled. J Nutr Biochem. 2002;13:645-652.
28. Sies H, Schewe T, Heiss C, et al. Cocoa polyphenols and inflammatory mediators. Am J Clin Nutr. 2005;81(1 Suppl):304S-312S.
29. Lotito SB, Actis-Goretta L, Renart L, et al. Influence of oligomer chain length on the antioxidant activity of procyanidins. Biochem Biophys Res Commun. 2000;276:945-951.
30. Wiswedel I, Hirsch D, Kropf S, et al. Flavanol-rich cocoa drink lowers plasma F(2)-isoprostane concentrations in humans. Free Radic Biol Med. 2004;37:411-421.
31. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191-196.
32. Vlachopoulos C, Aznaouridis K, Alexopoulos N, et al. Effect of dark chocolate on arterial function in healthy individuals. Am J Hypertens. 2005;18:785-791.
33. Schroeter H, Heiss C, Balzer J, et al. (-)-epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA. 2006;103:1024-1029.
34. Fisher ND, Hughes M, Gerhard-Herman M, et al. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens. 2003;21:2281-2286.
35. Heiss C, Kleinbongard P, Dejam A, et al. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol. 2005;46:1276-1283.
36. Heiss C, Finis D, Kleinbongard P, et al. Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J Cardiovasc Pharmacol. 2007;49:74-80.
37. Rein D, Paglieroni TG, Wun T, et al. Cocoa inhibits platelet activation and function. Am J Clin Nutr. 2001;72:30-35.
38. Pearson DA, Paglieroni TG, Rein D, et al. The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function. Thromb Res. 2002;106:191-197.
39. Murphy KJ, Chronopoulos AK, Singh I, et al. Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr. 2003;77:1466-1473.
40. Becker DM, Yanek LR, Moy TF, et al. Casual chocolate consumption and inhibition of platelet function. Prev Cardiol. 2007;10:175-180.
41. Grassi D, Lippi C, Necozione S, et al. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr. 2005;81:611-614.
42. Grassi D, Necozione S, Lippi C, et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension. 2005;46:398-405.
43. Actis-Goretta L, Ottaviani JI, Fraga CG. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem. 2006;54:229-234.
44. Buijsse B, Feskens EJ, Kok FJ, et al. Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. Arch Intern Med. 2006;166:411-417.
45. Taubert D, Roesen R, Schömig E. Effect of cocoa and tea intake on blood pressure. A meta-analysis. Arch Intern Med. 2007;167:626-634.
46. Buyn J, Mueller DM, Fabjan JS, et al. Nitrogen dioxide radical generated by the myeloperoxidase-hydrogen peroxide system promotes lipid peroxidation of low-density lipoprotein. FEBS Lett. 1999;455:243-246.
47. Schroeder P, Klotz LO, Buchczyk DP, et al. Epicatechin selectively prevents nitration but not oxidation reactions of peroxynitrite. Biochem Biophys Res Commun. 2001;285:782-787.
48. Fogliatto G, Musanti R, Pirillo A, et al. Oxidized lipoproteins induce long-lasting inhibition of nitric oxide synthase from a murine endothelioma cell line (bEnd.4). J Cardiovasc Risk. 1995;2:123-130.
49. Arteel GE, Schroeder P, Sies H. Reactions of peroxynitrite with cocoa procyanidin oligomers. J Nutr. 2000;130(8S Suppl):2100S-2104S.
50. Steffen Y, Schewe T, Sies H. Epicatechin protects endothelial cells against oxidized LDL and maintains NO synthase. Biochem Biophys Res Commun. 2005;331:1277-1283.
51. Schramm DD, Wang JF, Holt RR, et al. Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells. Am J Clin Nutr. 2001;73:36-40.
52. Schewe T, Kuhn H, Sies H. Flavonoids of cocoa inhibit recombinant human 5-lipoxygenase. J Nutr. 2002;132:1825-1829.
53. Mao T, Powell J, Van De Water J, et al. The effect of cocoa procyanidins on the transcription and secretion of interleukin-1β in peripheral blood mononuclear cells. Life Sci. 2000;66:1377-1386.
54. Mackenzie GG, Carrasquedo F, Delfino JM, et al. Epicatechin, catechin, and dimeric procyanidins inhibit PMA induced NF-κB activation at multiple steps in Jurkat T cells. FASEB J. 2003;18:167-169.
55. Frishman WH, Sinatra ST, Kruger N. Nutriceuticals and cardiovascular illness. In: Frishman WH, Weintraub MI, Micozzi MS, eds. Complementary and Integrative Therapies for Cardiovascular Disease. Philadelphia, PA: Elsevier/Mosby; 2005:58-85.
56. Petchetti L, Frishman WH, Petrillo R, et al. Nutriceuticals in cardiovascular disease: psyllium. Cardiol Rev. 2007;15:116-122.
57. Cohen DL, Townsend RR. Cocoa ingestion and hypertension - another cup please? J Clin Hypertens. 2007;9:647-648.